Covalon Technologies (OTCMKTS:CVALF) Announces Earnings Results

Covalon Technologies (OTCMKTS:CVALF) posted its earnings results on Thursday. The company reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02, Zacks reports. The company had revenue of $6.27 million for the quarter, compared to the consensus estimate of $6.70 million. Covalon Technologies had a return on equity of 5.74% and a net margin of 5.05%.

Covalon Technologies Stock Performance

CVALF opened at $1.44 on Friday. The business’s fifty day moving average is $1.38 and its two-hundred day moving average is $1.33. The company has a market cap of $39.83 million, a price-to-earnings ratio of 36.06 and a beta of 0.59. Covalon Technologies has a one year low of $1.16 and a one year high of $2.14.

Covalon Technologies Company Profile

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.

The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.